Metraipolis › archive › dc_6a8fa741fe57

Targeting cancer expressed EGFR with a humanized monoclonal antibody — Europe PMC PMID:41904250

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41904250
DOI
10.1038/s41598-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-03T19:10:54.889Z
SHA-256 of the archived text
25b5d849c621544e7323fffe14a3793ed2be6e9bccf4134f01ded9a56bbfad6c
Stable URL of this page
https://metraipolis.com/documento/dc_6a8fa741fe57

How to cite

Targeting cancer expressed EGFR with a humanized monoclonal antibody — Europe PMC PMID:41904250 — Europe PMC (en), https://europepmc.org/article/MED/41904250 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6a8fa741fe57 (Metraipolis archive dc_6a8fa741fe57, sha256 25b5d849c621544e7323fffe14a3793ed2be6e9bccf4134f01ded9a56bbfad6c)
BibTeX
@misc{dc6a8fa741fe57,
  title = {Targeting cancer expressed EGFR with a humanized monoclonal antibody — Europe PMC PMID:41904250},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41904250},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6a8fa741fe57; sha256 25b5d849c621544e7323fffe14a3793ed2be6e9bccf4134f01ded9a56bbfad6c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41904250. Agents can read the archived copy with the MCP tool read_document.